BC
DXTR

Broadfin Capital’s Dextera Surgical Inc. DXTR Stock Holding History

Broadfin Capital’s Portfolio DXTR Stock Details DXTR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q3 		– Sell
-987,520
Closed -$296K – 59
2017
Q2 		$296K Buy
987,520
+388,080
+65% +$196K 0.04% 53
2017
Q1 		$635K Sell
599,440
-236,927
-28% -$304K 0.08% 53
2016
Q4 		$803K Sell
836,367
-7,800
-0.9% -$11.7K 0.09% 62
2016
Q3 		$1.59M Sell
844,167
-18,332
-2% -$39K 0.14% 67
2016
Q2 		$1.55M Buy
+862,499
New +$1.77M 0.15% 62

Other funds holding DXTR

Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
VF
Virtu Financial New York $2.41B AUM 48.35% 1-Year Est. Return
PCM
Perkins Capital Management Wayzata, Minnesota $133M AUM 127.86% 1-Year Est. Return
WS
Wedbush Securities Los Angeles, California $3.43B AUM 24.13% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
LTFS
Ladenburg Thalmann Financial Services Miami, Florida $15.9B AUM 25.16% 1-Year Est. Return
PAG
Private Advisor Group Morristown, New Jersey $21.3B AUM 22.13% 1-Year Est. Return

Broadfin Capital's DXTR Position: Q3 2017 in Review

Broadfin Capital sold out of Dextera Surgical Inc. (DXTR) in Q3 2017, closing a stake of 987,520 shares — an estimated $296K sold.

Broadfin Capital first reported a position in DXTR in Q2 2016 and held it in 5 quarters. The position peaked at $1.59M in Q3 2016. 23 funds tracked by Wall St. Rank hold DXTR as of Q3 2017.

  • Broadfin Capital reported no remaining Dextera Surgical Inc. position as of Q3 2017 after selling out during the quarter.
  • Broadfin Capital sold 987,520 Dextera Surgical Inc. shares in Q3 2017, an estimated $296K.
  • Broadfin Capital first reported a position in Dextera Surgical Inc. in Q2 2016 and held it in 5 quarters.
  • Broadfin Capital's Dextera Surgical Inc. position peaked at $1.59M in Q3 2016.
  • 23 funds tracked by Wall St. Rank held Dextera Surgical Inc. as of Q3 2017.

Based on Broadfin Capital's 13F filing for Q3 2017, filed 14 Nov 2017.